These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33463683)

  • 1. Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    Mason CY; Kanitkar T; Richardson CJ; Lanzman M; Stone Z; Mahungu T; Mack D; Wey EQ; Lamb L; Balakrishnan I; Pollara G
    J Antimicrob Chemother; 2021 Apr; 76(5):1323-1331. PubMed ID: 33463683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory response in mixed viral-bacterial community-acquired pneumonia.
    Bello S; Mincholé E; Fandos S; Lasierra AB; Ruiz MA; Simon AL; Panadero C; Lapresta C; Menendez R; Torres A
    BMC Pulm Med; 2014 Jul; 14():123. PubMed ID: 25073709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of bacterial and viral community-acquired pneumonia in children.
    Don M; Valent F; Korppi M; Canciani M
    Pediatr Int; 2009 Feb; 51(1):91-6. PubMed ID: 19371285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
    Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
    J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.
    Yoon NB; Son C; Um SJ
    Ann Lab Med; 2013 Mar; 33(2):105-10. PubMed ID: 23482854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.
    Bhuiyan MU; Blyth CC; West R; Lang J; Rahman T; Granland C; de Gier C; Borland ML; Thornton RB; Kirkham LS; Martin A; Richmond PC; Smith DW; Jaffe A; Snelling TL
    BMC Pulm Med; 2019 Apr; 19(1):71. PubMed ID: 30940126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
    J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consecutive Measures of CRP Correlate with Length of Hospital Stay in Patients with Community-Acquired Pneumonia.
    Farah R; Khamisy-Farah R; Makhoul N
    Isr Med Assoc J; 2018 Jun; 20(6):345-348. PubMed ID: 29911753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by infection with SARS-CoV-2, bacteria, and influenza.
    Hegelund MH; Glenthøj A; Ryrsø CK; Ritz C; Dungu AM; Sejdic A; List KCK; Krogh-Madsen R; Lindegaard B; Kurtzhals JAL; Faurholt-Jepsen D
    APMIS; 2022 Sep; 130(9):590-596. PubMed ID: 35751642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ).
    Rothe K; Spinner CD; Panning M; Pletz MW; Rohde G; Rupp J; Witzenrath M; Erber J; Eberhardt F; Essig A; Schneider J;
    Infection; 2021 Dec; 49(6):1299-1306. PubMed ID: 34687426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
    Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE;
    Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Papassotiriou J; Kunde J; Marre R; von Baum H; Suttor N; Welte T;
    Respir Res; 2009 Jul; 10(1):65. PubMed ID: 19594893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Procalcitonin, White Blood Cell and Hypersensitive C-reactive Protein Combined with Age Established a New Prediction Model in Predicting ICU Admission in Adult Community-Acquired Pneumonia (CAP) Patients.
    Li WQ; Chen Y; Liu TJ; Xie BQ; Fu AS; Li LQ; Ge YL; Min P; Lu Y; Liu Y; Sun Y; Hou LL; Jing Q; Zhang HF; Zhang JB
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
    Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.